Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Acorda’s MS Drug May Need More Study, U.S. FDA Says
Acorda’s MS Drug May Need More Study, U.S. FDA Says
Acorda’s MS Drug May Need More Study, U.S. FDA Says
Submitted by
admin
on October 9, 2009 - 9:29am
Source:
Bloomberg
News Tags:
Acorda Therapeutics
MS
multiple sclerosis
Fampridine-SR
Headline:
Acorda’s MS Drug May Need More Study, U.S. FDA Says
Do Not Allow Advertisers to Use My Personal information
